HIV Negative Clinical Trials

1. A phase 2 clinical trial to evaluate the safety and immunogenicity of a prime-boost vaccine regimen of pGA2/JS7 DNA and MVA/HIV62, in healthy, HIV uninfected vaccinia-naive adult participants